• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

News of the day

PR Newswire search

Most viewed

Diabetes Online Health Guide Released on NHS Choices

Risk Management: Best Practices for Medical Device Profitability

Egyptian Foot Care Centre to Improve Diabetes Foot Care With Grant From the International Diabetes Federation

Britain's Plaque Plague Costing NHS More Than GBP 2 Billion

Dubai Health Authority Unveils Healthcare for All

More recent news

Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
2nd October 2008 STOCKHOLM, October 2 /PRNewswire/ -- Athera Biotechnologies AB and Dyax Corp. (NASDAQ:DYAX) announced today that they have entered into a collaboration to discover and to develop therapeutic products...

Driving Change in Mental Health Through Science and Community
2nd October 2008 BEERSE, Belgium, October 2 /PRNewswire/ -- Today, Janssen-Cilag are celebrating their 50 year commitment to researching and developing innovative medicines to help improve the lives of people with...

Bayer's Novel Oral Anticoagulant Xarelto(R) (Rivaroxaban) Gets European Licence
2nd October 2008 NEWBURY, England, October 2 /PRNewswire/ -- A new drug launched today could help in the fight against what experts and campaigners are calling a 'major patient safety issue'(1) - the prevention of...

Shire's Vyvanse Will Attain Blockbuster Status by 2017 in the Attention-Deficit/Hyperactivity Disorder Drug Market
29th September 2008 WALTHAM, Massachusetts, September 29 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Shire's...

Health Experts Call for New Strategies to Combat Alarming Rise in Diabetes
25th September 2008 PARIS, September 25 /PRNewswire/ -- Experts have predicted that by 2025, the number of people with diabetes will have increased by 20 per cent within Europe, 80 percent within Eastern Mediterranean...

RPSGB Responds to Which? Report
25th September 2008 LONDON, September 25 /PRNewswire/ -- The Royal Pharmaceutical Society of Great Britain (RPSGB) has responded to the 2008 Which? report, A test of your own medicine. David Pruce, Director of...

Bringing Diabetes to Light: International Diabetes Federation Encouraging Citizens to Raise Awareness and Protect Future Generations
25th September 2008 BRUSSELS, Belgium, September 25 /PRNewswire/ -- The International Diabetes Federation announced today that it is calling on groups and individuals worldwide to get involved in activities to...

Landmark UPLIFT Study Reaffirms the Safety of Spiriva (tiotropium) in Patients With Chronic Obstructive Pulmonary Disease
24th September 2008 LEUVEN, Belgium, September 24 /PRNewswire/ -- Placebo-controlled, randomised, double-blind clinical trials provide the most comprehensive and strongest evidence of a drug's safety profile....

Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
23rd September 2008 COLLEGEVILLE, Pennsylvania, September 23 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the initiation of the Community Acquired Pneumonia Immunization Trial...

PHM Emerging Markets Healthcare Monitor Publishes Risks Report
23rd September 2008 SEBASTIAN, Florida, September 23 /PRNewswire/ -- PHM International, Inc. a worldwide healthcare consultancy has published its report on investment and security risks due to the growing shortage...

New Data Supports the Safety Record of ENBREL(R) as a Continuous Therapy in Children and Adolescents With Juvenile Idiopathic Arthritis
23rd September 2008 MAIDENHEAD, England, September 23 /PRNewswire/ -- Wyeth today announced study results from last week's 15th Paediatric Rheumatology European Congress (PRES) in London which highlight the...

National Survey Shows UK Women Often Ignore Vaginal Infections
23rd September 2008 LONDON, September 23 /PRNewswire/ -- Results of a recent survey reveal symptoms of vaginal discomfort are being ignored by women. Nearly 50% of women suffer from vaginal discomfort and yet around...

U.S. Company May Have Silver Bullet In Vitamin D Fight Against Disease
22nd September 2008 WILMINGTON, Massachusetts, September 22 /PRNewswire/ -- Xenon Corp., a company internationally recognized as a leader and pioneer in the field of Pulsed Light systems, might have found the silver...

Rose-Hip Powder May Protect and Rebuild Joint Tissues
22nd September 2008 GLOUCESTER, England, September 22 /PRNewswire/ -- The latest evidence for the unique joint-protection properties of a patented rose-hip powder - which is proving increasingly popular with sufferers...

Hospitals Must Take up Challenge to Tackle Clots
19th September 2008 LONDON, September 19 /PRNewswire/ -- A new tool to help hospital doctors screen for Britain's most dangerous hospital killer is being rolled out across the country today and has the potential to save...

Global Psychiatrists Unite to Improve Services in Mental Health
19th September 2008 INNSBRUCK, Austria, September 19 /PRNewswire/ -- Thirty seven medical experts in psychiatry from across the world have called on the medical community to take urgent action to optimize services for...

Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis
18th September 2008 GENEVA, Switzerland, September 18 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the initiation of a Phase III trial to evaluate the therapeutic...

Latest RAD001 Study Results Show Further Increase in Time Without Tumour Growth in Patients With Advanced Kidney Cancer
17th September 2008 FRIMLEY, England, September 17 /PRNewswire/ -- New data continue to demonstrate the potential benefit of RAD001 (everolimus) for patients with advanced kidney cancer who have failed standard...

Sex Bomb - What Really Turns Us On in the Naughty 'Noughties'?
17th September 2008 LONDON, September 17 /PRNewswire/ -- Marie Stopes International (MSI), the UK's leading sexual health agency, today launches its Sex Bomb campaign to discover what sex and relationships mean to...

Top Pharmaceutical Websites Visited by European Consumers Revealed
16th September 2008 NEW YORK, September 16 /PRNewswire/ -- Manhattan Research, a leading provider of access to physician and consumer opinions on the global healthcare market, reveals today the top pharmaceutical web...

SemBioSys Eligible to Proceed With Phase I/II Plant-Produced Insulin Trial After Submission of IND
16th September 2008 CALGARY, Canada, September 16 /PRNewswire/ -- SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases,...

Custom-Milled Final Abutment Market to Rise by Almost 30% Annually Through 2012, According to Millennium Research Group
16th September 2008 WALTHAM, Massachusetts, September 16 /PRNewswire/ -- According to Millennium Research Group's (MRG's) European Markets for Dental Implants 2008 report, the rising demand for...

InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
16th September 2008 BRITISH COLUMBIA, Canada, September 16 /PRNewswire/ -- InNexus Biotechnology Inc. (TSX VENTURE: IXS; OTC Bulletin Board: IXSBF; http://www.ixsbio.com), a drug development company commercializing the...

Successful Results for Mymetics Corporation's Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
16th September 2008 NYON, Switzerland, September 16 /PRNewswire/ -- Mymetics Corporation (OTCBB: MYMX), a vaccine development company, is pleased to announce their preliminary SHIV challenge results on non-human...

More People With Down Syndrome Are Being Born, Achieving More and Living Longer Than Ever Before
16th September 2008 PORTSMOUTH, England, September 16 /PRNewswire/ -- A new analysis shows that many more babies are being born with Down syndrome today than 15 years ago in England, despite universally...

Astonishing 52 percent of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs in First-Line Treatment
16th September 2008 WALTHAM, Massachusetts, September 16 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that...

New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
16th September 2008 BASEL, Switzerland, September 16 /PRNewswire/ -- Avastin (bevacizumab) remains the only biologic to provide overall survival (OS) benefit when used as first-line treatment in combination...

Top Pharmaceutical Websites Visited by European Consumers Revealed
15th September 2008 NEW YORK, September 15 /PRNewswire/ -- Physician interest in live video detail from sales reps is growing, Manhattan Research, a leading provider of access to physician and consumer opinions on the...

AVAiL Study Shows Longest Survival in Patients With Advanced Non-Small Cell Lung Cancer
15th September 2008 BASEL, Switzerland, September 15 /PRNewswire/ -- The final analysis of the Avastin in lung study (AVAiL) in patients with advanced lung cancer has shown that not only did the drug significantly...

Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R)
15th September 2008 WELLESLEY HILLS, Massachusetts, September 15 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee of the assets of Spherics, Inc. ("Spherics") for the benefit of creditors, announced today...

Pan-European Research Reveals Majority of Osteoporosis Patients not Receiving Recommended Combination of Calcium and Vitamin D With Treatment
15th September 2008 GENEVA, September 15 /PRNewswire/ -- New research published today at the annual meeting of the American Society for Bone and Mineral Research (ASBMR), Montr

Emerging Therapies, Including Bristol-Myers Squibb/Medarex's Ipilimumab, Will Drive Growth in the Malignant Melanoma Drug Market
15th September 2008 WALTHAM, Massachusetts, September 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the...

Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease
15th September 2008 KAKAMEGA, Kenya, September 15 /PRNewswire/ -- A new approach to fighting malaria, diarrhoeal diseases and HIV was launched today in the Western Kenyan district of Kakamega in Lurambi division. ...

Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
10th September 2008 PARIS, September 10 /PRNewswire/ -- Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of...

Manpower Software plc Announces a Record First Quarter of New NHS Trust Wins in the UK Healthcare Market
10th September 2008 LONDON, September 10 /PRNewswire/ -- Manpower Software plc, the leading provider of workforce optimisation applications in the UK healthcare market, is pleased to announce during the company's first...

The Work Foundation Announces New Work Programmes
9th September 2008 LONDON, September 9 /PRNewswire/ -- The Work Foundation today announces changes to its structure and focus to consolidate its position as the leading research and consultancy...

Urology Week, 15-19 September, Asks Attention for Urological Conditions
9th September 2008 ARNHEM, The Netherlands, September 9 /PRNewswire/ -- Every year 346,000 new cases of prostate cancer are detected in Europe, every day 240 men die of the condition. At least 1 in 10 people age 65...

New HIV Protection for Women
9th September 2008 MANCHESTER, England, September 9 /PRNewswire/ -- Vaginal rings, similar to those used for contraception and hormone replacement therapy, could protect women from sexually-transmitted HIV, according...

Simple Test to Detect Fake Medicines
9th September 2008 MANCHESTER, England, September 9 /PRNewswire/ -- The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether...

Coated Catheters Reduce Infection Risk
9th September 2008 MANCHESTER, England, September 9 /PRNewswire/ -- A new coating for urinary catheters could reduce the risk of infection, according to research presented at the British Pharmaceutical Conference (BPC)...

Worms Wiggle Into Gene Therapy
9th September 2008 MANCHESTER, England, September 9 /PRNewswire/ -- Egg secretions from a worm that causes a deadly human disease may prove useful in gene therapy, according to research presented at the...

Pharmacists Reduce Hospital Visits for Respiratory Patients
9th September 2008 MANCHESTER, England, September 9 /PRNewswire/ -- Patients with chronic obstructive pulmonary disease (COPD) experience 55% fewer hospital admissions and 50% less visits to accident and...

Saxagliptin Improved Key Measures of Glucose Control When Added to a Sulphonylurea or Thiazolidinedione in People With Inadequately Controlled Type 2 Diabetes
8th September 2008 ROME, September 8 /PRNewswire/ -- Results from two 24-week Phase III studies presented at the 44th European Association for the Study of Diabetes Annual Meeting demonstrate that saxagliptin, an...